One more year, we publish our annual scientific report, available from the Hospital’s intranet and from the Institute’s website.
Next December 13th, Madrid ADVANTAGE Joint Action Forum Will take place in the Ministerio de Sanidad, Consumo y Bienestar Social
The objective of the event will be to discuss the report “Strategy for the prevention of fragility” with the representation of Health of the Member States participating in ADVANTAGE JA and the interest groups. It is about defining how those responsible for health policies can take on the recommendations of ADVANTAGE JA and the role of civil society in the prevention of fragility in the EU. All this also taking into account the different European political, social and professional contexts that favor its implementation.
In addition, will be announced all the activities of the campaign “Plántale cara a la fragilidad!” in order to sensitize public opinion, health managers, elderly people, caregivers, health professionals, researchers … of importance and need to act on this topic.
The EU and the 22 Member States that participate, co-finance through the Public Health Program 2014-2020 Joint Action Joint Action (JA) – ADVANTAGE JA for the prevention of frailty. For three years, the 33 member institutions will establish a common European framework to address the problem of frailty, the main risk factor associated with disability in older people. ADVANTAGE JA is coordinated by Spain, specifically by the University Hospital of Getafe of the Madrid Health Service.
Registration is open until November 26 from the following link:
The Foundation for Biomedical Research of the University Hospital of Getafe starts a crowdfunding campaign on the prevention of frailty and dementia through the platform “PRECIPITA” of the Spanish Foundation for Science and Technology (FECYT) to attract the necessary funding to develop the research project “Ageing brain” on prevention of diseases associated with age, such as frailty and dementia.
Last June 2018 the II Meeting of Shakeholders of ADVANTAGE JA, took place in Valencia (Spain), with the slogan “Attention to fragility, a challenge and an opportunity for our society”.
ADVANTAGE JA, is the first common initiative on the prevention of frailty in Europe. It will contribute to a more homogeneous approach to frailty, improving its screening, diagnosis, prevention and treatment, as well as the reform of socio-health systems and reorienting priorities in European training and research programs towards the prevention of disability.
A Panel of Experts in order to produce a common conceptual framework for further work and for future social-health policy recommendations have met in this day to give greater visibility to the phenomenon of frailty, to emphasize its importance, review the various actions that are taking place at this time to address this phenomenon in our country, and present different opportunities for improvement in the management of the same.
Emphasis has been placed on the role of informal carers and caregivers of fragile people, as well as on the application of new biomedical and biomechanical technologies in order to improve the detection of frailty and the improvement of the quality of life of people who suffer it.
- State of the art report on the prevention and management of frailty (January 2018) [en]
- Informe divulgativo sobre el estado del arte en la prevención y manejo de la fragilidad (Mayo 2018) [es]
More information about ADVANTAGE JA at: www.advantageja.eu Twitter: @advantageJA Facebook: https://www.facebook.com/advantageJA/
The FACET project, led by Abbott, opens a new registration period for the free course “Recognizing Frailty”, whose program will run for two weeks and has begun on June 18.
Organized by Abbott in collaboration with Aberystwyth University, the formation of this MOOC is to raise awareness about the frailty of older people. Those interested can register by clicking here.
FACET (FrAilty Care and wEll-funcTion), a project framed within the EIT Health Consortium, focuses on the prevention of frailty by monitoring and improving the health of older adults. Its objective is to raise awareness of the frailty among the general population, especially the elderly and professionals, and to promote new strategies.
The Foundation for Biomedical Research of the University Hospital of Getafe, participates as a partner in this project, under the direction of Dr. Rodríguez Mañas.
The course will offer free materials and workshops for doctors and other professionals around the assessment of functional capacity and the assessment of frailty. The content of the course will cover the importance of monitoring frailty, signs and symptoms and risk factors, as well as strategies to determine frailty in older people and solutions in current clinical practice.
More information about the course in: http://waru.org.uk/cms/projects/facet/facet-mooc/ Registry: http://waru.org.uk/cms/projects/facet/facet-mooc/recognising-frailty-mooc-registration/
Laste 18, the Deputy Minister of Humanization of the Sanitary Assistance of the Community of Madrid, Diego Sanjuanbenito, has closed the Closing Meeting of the FRAILOMIC Project, coordinated by the Geriatrics team of the Universitary Hospital of Getafe, which has involved 27 institutions from 7 countries of the European Union (EU) and WHO with the aim of improving the ability to detect and predict frailty, which is the main risk factor for the development of disability in the elderly. Currently, it is considered that frailty is the main element on which health authorities can act to promote a healthy aging of the population.
The FRAILOMIC initiative is a large scale research project aiming to identify the factors that turn frailty into disability.
The anticipated rise in the number of older people this century will inevitably be accompanied by an increase in the number of people with disabilities. Frailty, which comprises changes associated with ageing and chronic disease, usually precedes disability. Detecting frailty and intervening before it becomes disabling is more and more necessary as the population ages. Testing the clinical utility of the existing definition of frailty using a combination of clinical and laboratory biomarkers is pivotal.
The FRAILOMIC initiative is designed to use biomarkers to determine the factors that turn frailty into disability. The main objective is to develop clinical instruments to predict the risk of frailty, improve the diagnostic accuracy of frailty in day-to-day practice, and to assess the prognosis of frailty in terms of disability and other adverse outcomes.
The preliminary findings of the FRAILOMIC study indicate that health professionals and researchers will be able to have a “set” of indicators (data on the state of health) in the near future that will allow them to identify the elderly at risk of suffering disability. From here, treatments and preventive measures can be implemented to avoid, delay or limit the loss of functionality (ability to perform daily tasks such as walking, cooking, going out to buy, etc.).
According to the study, a series of indicators or health data related to inflammation, genetics and metabolism that are associated with frailty have been identified. This will allow the development and implementation of tools (analysis, scales, etc.) to measure this risk in the medical consultation.
LEADER IN EUROPEAN FRAILTY PROJECTS
Dr. Rodríguez Mañas, through the Geriatrics Service and the Biomedical Research Foundation of the University Hospital of Getafe, currently leads 3 important European research projects on frailty and the prevention of dependence in elderly patients (Frailclinic, Frailomic and Frailtools), financed by the EU with more than 19 million euros and involving 25 groups from 9 European countries and the WHO, having as main objectives the knowledge of the mechanisms of frailty in the elderly and the discovery of treatments that allow to reverse the state of fragility, avoiding or reducing disability. Also within the Area of Aging, the University Hospital of Getafe participates as a partner in four other research projects (Sprintt, Acanto, Deci and Facet) that have 2.1 million euros of EU funding. It also coordinates the Center for Biomedical Research in Network on Healthy Fragility and Aging (CIBERfes), within the CIBER consortium of the Carlos III Health Institute. The Community of Madrid (Ministry of Health-Getafe Hospital) currently coordinates, by delegation of the Ministry of Health, and through the group of Dr. Rodríguez Mañas, the European Joint Action on Frailty Prevention in the Elderly, which aims to build a strategic framework for the preventive approach of this issue at a European level and favor collaboration between the States to help solve public health problems.